Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
Sponsor: Xijing Hospital
Summary
The purpose of this multicenter, prospective and observational registry is to evaluate the safety and efficacy of TAVR for treatment of pure severe aortic valve regurgitation. Baseline characteristics, procedural and clinical data will be collected
Official title: Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation: a Real-world, Prospective, Multicenter Study (TRUST TAVR Registry)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2018-10-30
Completion Date
2034-10
Last Updated
2024-04-24
Healthy Volunteers
No
Conditions
Interventions
Transcatheter aortic valve replacement
A total of 500 consecutive patients with NAVR undergoing TAVR will be enrolled at 3-5 centers. Clinical follow-up will be conducted in the periprocedural and after aortic valve implantation at 1 month, 1 year, 2 years, 3 years, 4 years, 5 years, and 10 years
Locations (1)
Xijing Hospital
Xi'an, Shannxi, China